Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma

Jean-Louis, G., & Cherng, H.-J. J. (2025). Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma. Cancers, 17(7), 1153. https://doi.org/10.3390/cancers17071153
Authors:
Gaston Jean-Louis
Hua-Jay J Cherng
Affiliated Authors:
Gaston Jean-Louis
Hua-Jay J Cherng
Columbia Affiliation:
Author Keywords:
bispecific antibodies
lymphoma
measurable residual disease
elink
Publication Type:
Article
Unique ID:
10.3390/cancers17071153
PMID:
40227652
DOI:
10.3390/cancers17071153
Journal:
Cancers
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: